Diabetes and prediabetes are dementia risk factors. They affect 1 in 7 adults! Learn about new research to lower that risk with lifestyle and drugs.
Is amyloid-beta plaque behind Alzheimer’s? A famous study proved “Yes”. Then news broke proving the study a fraud. Yet today’s best, newest Alzheimer’s drugs work by fighting plaque. Did fabricated scientific results accidentally set us on the path to a breakthrough?
AAIC 2024 is the Alzheimer’s Association’s International Conference. The world’s leading scientists, researchers, and clinicians gather to discuss the latest discoveries and upcoming research. Ranging from new biomarker blood tests to VR technology, see exciting and promising news coming from the 2024 conference.
Head-to-head study examined which blood tests most accurately detected amyloid plaques and other Alzheimer’s-related measures.
“60 Minutes” interviews American neurosurgeon Dr. Ali Rezai. He is pioneering a new way to treat Alzheimer’s, focusing beams of ultrasound on the brain.
In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.
LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.
Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.
A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?
At Thailand’s Vivo Bene Dementia Resort, pampering is the priority. This special report for 60 MINUTES asks, why can’t there be facilities like Vivo Bene in Australia?
We make a living by what we get,But we make a life by what we give. (Winston Churchill)
Clinical Psychology / Neuropsychology
LIFECARE PSYCHOLOGY GROUP, LLC
Empower yourself with a detailed report of your brain’s function, consisting of an assessment of your cognitive function and your brain connectivity with a quick 45-minute on-site appointment.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
